BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 37171501)

  • 1. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
    Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
    Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
    PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
    Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
    PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.
    Sun L; Ding H; Jia Y; Shi M; Guo D; Yang P; Wang Y; Liu F; Zhang Y; Zhu Z
    Breast Cancer Res; 2022 Feb; 24(1):12. PubMed ID: 35151363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
    Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
    Elife; 2022 Mar; 11():. PubMed ID: 35346416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.
    Sun X; Ping J; Guo X; Long J; Cai Q; Shu XO; Shu X
    Mol Carcinog; 2024 May; 63(5):849-858. PubMed ID: 38517045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
    Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
    EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.
    Au Yeung SL; Schooling CM
    BMJ Open Diabetes Res Care; 2019; 7(1):e000872. PubMed ID: 31908803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study.
    Soremekun O; Karhunen V; He Y; Rajasundaram S; Liu B; Gkatzionis A; Soremekun C; Udosen B; Musa H; Silva S; Kintu C; Mayanja R; Nakabuye M; Machipisa T; Mason A; Vujkovic M; Zuber V; Soliman M; Mugisha J; Nash O; Kaleebu P; Nyirenda M; Chikowore T; Nitsch D; Burgess S; Gill D; Fatumo S
    EBioMedicine; 2022 Apr; 78():103953. PubMed ID: 35325778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
    Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
    Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between Genetically Proxied Inhibition of Lipid-Lowering Drug Targets and Serum Micronutrients among Individuals of European Descent: A Mendelian Randomization Study.
    He JY; Zhang X; Wang K; Lv WQ
    J Nutr; 2022 May; 152(5):1283-1290. PubMed ID: 35349717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study.
    Au Yeung SL; Luo S; Schooling CM
    Diabetologia; 2019 Sep; 62(9):1638-1646. PubMed ID: 31161347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically proxied milk consumption and risk of colorectal, bladder, breast, and prostate cancer: a two-sample Mendelian randomization study.
    Larsson SC; Mason AM; Kar S; Vithayathil M; Carter P; Baron JA; Michaëlsson K; Burgess S
    BMC Med; 2020 Dec; 18(1):370. PubMed ID: 33261611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.
    Gormley M; Yarmolinsky J; Dudding T; Burrows K; Martin RM; Thomas S; Tyrrell J; Brennan P; Pring M; Boccia S; Olshan AF; Diergaarde B; Hung RJ; Liu G; Legge D; Tajara EH; Severino P; Lacko M; Ness AR; Davey Smith G; Vincent EE; Richmond RC
    PLoS Genet; 2021 Apr; 17(4):e1009525. PubMed ID: 33886544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer.
    Yarmolinsky J; Bull CJ; Vincent EE; Robinson J; Walther A; Smith GD; Lewis SJ; Relton CL; Martin RM
    JAMA; 2020 Feb; 323(7):646-655. PubMed ID: 32068819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of glucose-lowering drug target and risk of gastrointestinal cancer: a mendelian randomization study.
    Yang Y; Chen B; Zheng C; Zeng H; Zhou J; Chen Y; Su Q; Wang J; Wang J; Wang Y; Wang H; Jin R; Bo Z; Chen G; Wang Y
    Cell Biosci; 2024 Mar; 14(1):36. PubMed ID: 38504335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation.
    Harati H; Zanetti D; Rao A; Gustafsson S; Perez M; Ingelsson E; Knowles JW
    Diabetologia; 2019 May; 62(5):800-804. PubMed ID: 30810766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants.
    Larsson SC; Carter P; Kar S; Vithayathil M; Mason AM; Michaëlsson K; Burgess S
    PLoS Med; 2020 Jul; 17(7):e1003178. PubMed ID: 32701947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study.
    Tang B; Yuan S; Xiong Y; He Q; Larsson SC
    Diabetologia; 2020 Jul; 63(7):1305-1311. PubMed ID: 32270255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
    Dimitrakopoulou VI; Tsilidis KK; Haycock PC; Dimou NL; Al-Dabhani K; Martin RM; Lewis SJ; Gunter MJ; Mondul A; Shui IM; Theodoratou E; Nimptsch K; Lindström S; Albanes D; Kühn T; Key TJ; Travis RC; Vimaleswaran KS; ; ; ; Kraft P; Pierce BL; Schildkraut JM
    BMJ; 2017 Oct; 359():j4761. PubMed ID: 29089348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.